- 501 Orchard Road, #04-08 Wheelock Place, Singapore 238880
- (65) 6235 4429
- hello@vidaskinclinic.com
- (65) 9830 0597
Lip filler treatment should not be planned by volume alone. Hyaluronic acid (HA) fillers differ in elasticity, viscosity, cohesivity, and the way they integrate with tissue. These properties influence how a product supports shape, spreads within the tissue, and moves with the lips.
The lips are made up of thin, highly mobile tissue and have a rich vascular supply. Because they move constantly during speech and facial expression, both the filler and its placement must be suited to the patient’s anatomy and treatment goal. A product that is appropriate for the cheek may not be the most suitable choice for the lips.
Hyaluronic acid fillers are characterised by their rheology, which describes how a gel responds to different types of force. These properties vary between products and help the doctor select a filler according to the treatment area, injection plane, and intended result.
G-prime (G′), or elastic modulus, describes how strongly a gel resists deformation and retains its shape when force is applied. Viscosity refers to its resistance to flow, while cohesivity describes how well the gel holds together rather than separating into smaller fragments.
A review of the rheological and physicochemical properties of HA fillers described higher-G′ products as more suitable for thicker tissue and deeper injection planes, while lower-G′ products may be more appropriate for superficial placement. Product studies also show that differences in crosslinking and gel structure create distinct profiles for different clinical purposes.
These measurements should still be interpreted with care. G′ values reported by different manufacturers may not be obtained under identical testing conditions, which limits direct comparison across brands. Rheology is therefore one part of product selection rather than a ranking system on its own.
The perioral region includes the lips and surrounding tissues. It combines thin cutaneous and mucosal tissue, constant movement from the orbicularis oris muscle, and blood vessels that may lie close to commonly used injection planes.
Anatomical studies of HA filler injection highlight the importance of understanding the depth and course of facial vessels to minimise vascular complications and improve treatment safety. Reviews of lip rejuvenation and perioral filler complications similarly highlight the importance of anatomy, appropriate technique and early recognition of complications.
For this reason, lip treatment requires the product, injection depth, volume and technique to be selected for the specific area being treated. It should not simply follow the same approach used for less mobile parts of the face.
A well-planned lip treatment aims to improve shape, proportion, definition or hydration while preserving natural movement and expression.
Softer products with a lower elastic modulus are often selected for the body of the lip because they can integrate more readily with thin, mobile tissue. This may help the lips remain supple and reduce the likelihood of the product feeling firm or appearing separate from the surrounding tissue.
However, softer is not always better for every part of the lip. The vermilion border and lip body have different structural requirements, and products developed for lip and perioral augmentation have been studied for these specific indications. Selection should therefore depend on the area being treated and the intended outcome. The doctor should consider the balance between softness, support, and tissue integration rather than relying on one property alone.
Because the lips move during speech, smiling, and pursing, the result should be assessed both at rest and during animation. A product that is too firm for the injection plane or treatment goal may feel less supple or appear less natural when the lips move.
Placement and volume are equally important. Filler placed too superficially or beyond the vermilion border may become more noticeable during animation. Assessing the lips while the patient talks, smiles, and purses allows the doctor to understand baseline movement and plan treatment more accurately.
Different parts of the lips may require different product characteristics. A softer gel may be preferred where smooth integration and movement are the priorities, while a more cohesive product may be considered where definition or structural support is needed.
Tissue integration is particularly important in the body of the lip and around the wet-dry junction, where the tissue is thin and mobile. The aim is for the filler to distribute smoothly within the surrounding tissue rather than remain visible or palpable as a distinct mass.
A conservative approach allows the doctor to assess how the lips respond before deciding whether additional volume is required. This can help preserve facial proportions and reduce the risk of overcorrection.
Where the aim is to define the vermilion border, support the philtral columns or improve structural projection, a more cohesive product that resists spreading may be considered. Rheological differences are clinically relevant because the desired behaviour varies between treatment zones.
In practice, this may involve selecting different products for different parts of the lips, or varying the technique and injection depth with the same product. The entire lip does not necessarily need to be treated in an identical way.
Like any injectable procedure, lip filler treatment carries risks. A proper consultation should explain the expected side effects, less common complications, and how the clinic would recognise and manage a problem if it occurred.
Hyaluronidase is an enzyme that breaks down hyaluronic acid, allowing HA filler to be dissolved when clinically appropriate. It may be used to adjust an unsatisfactory aesthetic result and, more urgently, as part of the management of a suspected vascular occlusion.
Published cases describe the use of high-dose pulsed hyaluronidase in the management of filler-related vascular occlusion and emphasise early recognition and prompt treatment. Other reports describe hyaluronidase as part of a broader complication-management protocol. Reference texts on filler complications also address its role in clinical management.
Hyaluronidase can itself cause adverse reactions, including hypersensitivity, and should be administered by a doctor following clinical assessment. Dissolving filler is therefore a medical procedure rather than a routine cosmetic reversal.
The ability to dissolve HA filler provides an additional management option that is not available with permanent fillers. In a suspected vascular occlusion, early recognition and treatment are important, so patients may wish to ask whether the clinic has an appropriate emergency protocol and access to hyaluronidase.
Reversibility may also allow an unsatisfactory aesthetic result to be adjusted or dissolved, although the response is not always completely predictable and further review may be needed. Permanent fillers do not offer the same option.
A consultation should explain not only what the doctor recommends, but also why a particular product, technique, and volume have been selected for your lips.
Questions you may wish to ask include:
Under Singapore’s regulatory framework, both the product and the practitioner can be checked. HSA requires Class B, C and D medical devices to be registered before they are supplied in Singapore. The SMC Guidelines on Aesthetic Practices for Doctors set out which doctors may perform aesthetic procedures and the relevant training or competency requirements. They also emphasise informed consent, including discussion of the intended benefits, limitations, potential risks and reasonable alternatives. Patients can verify a doctor’s registration status and specialist accreditation through the Ministry of Health’s public Professional Register. These checks do not guarantee a particular result, but they help confirm that treatment is being provided within the appropriate professional and regulatory framework. A clear consultation should therefore identify the intended product, the treating doctor and the clinical rationale before consent is given. Patients should also receive enough information and time to consider whether the recommendation is appropriate for them.
Consider asking for clarification or seeking another opinion if you encounter:
Lip filler is an elective procedure, and patients should have sufficient time to consider the recommendation. A clinic should be comfortable with you asking questions or deciding after the consultation rather than immediately.
A natural-looking lip filler result depends not only on how much product is used, but also on whether the product, injection plane, and volume are appropriate for the patient’s anatomy and goals.
At VIDASKIN, lip filler treatment begins with an assessment of lip anatomy, facial proportions, tissue quality, dynamic movement, and the changes the patient would like to achieve. The product and technique are selected after this assessment, and a conservative amount or an alternative treatment may sometimes be more appropriate.
To learn more or book a consultation, visit us here today.
HSA maintains the Singapore Medical Device Register for registered medical devices. Patients can ask the doctor to identify the specific product being used and confirm that it is registered for supply in Singapore.
